Pure Bioscience's total assets for Q3 2024 were $920.00K, a decrease of -15.29% from the previous quarter. PURE total liabilities were $666.00K for the fiscal quarter, a -72.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.